About the Journal

About the Journal

About the ASIDE Oncology Journal

Vision and Mission

The ASIDE Oncology Journal is a peer-reviewed, open-access journal committed to advancing diversity, equity, inclusion, and accessibility in oncology through scholarly publication. As an integral part of ASIDE Healthcare, the journal strives to reflect these values in all its activities and publications.

Our mission is to advance the field of oncology by promoting innovative research, evidence-based practices, and transformative ideas that prioritize health equity. We aim to serve as a platform for voices historically underrepresented in cancer research, offering insights that challenge traditional narratives and foster a more inclusive oncology landscape.

Scope

ASIDE Oncology publishes original research articles, reviews, clinical case studies, and commentary across all subspecialties of oncology. This includes, but is not limited to, medical oncology, surgical oncology, radiation oncology, hematologic malignancies, cancer epidemiology, palliative care, supportive oncology, and cancer survivorship. We particularly value contributions that address the impact of social determinants of health, innovative patient care strategies for underserved cancer populations, health disparities, and interdisciplinary approaches to complex oncologic challenges.

Readership

Our readership includes oncologists, cancer researchers, multidisciplinary healthcare professionals, policy makers, advocates, and educators who are dedicated to transforming cancer care and outcomes for all. With a global outreach, ASIDE Oncology invites submissions from around the world to foster diverse, international dialogue in oncology.

Open Access Policy

In line with our commitment to accessibility, the ASIDE Oncology Journal provides immediate open access to its content, based on the principle that making cancer research freely available supports a greater global exchange of knowledge. This ensures that our articles are accessible to a wide audience, promoting the dissemination of research findings and innovations without barriers.

Editorial Process

Our rigorous peer-review process ensures the publication of high-quality research. The journal upholds the highest standards of peer review, managed by an international editorial board dedicated not only to advancing oncologic science but also to upholding fairness, diversity, and inclusiveness in academic publishing.

Peer Review Policy for ASIDE Oncology: Double-Blind Process

Introduction to Peer Review

1.1 What is Peer Review?
Peer review is a critical process used to ensure the quality and integrity of manuscripts prior to publication. Independent experts assess submissions for originality, validity, and significance to assist editorial decisions about publication suitability.

1.2 Purpose of Peer Review in ASIDE Oncology
Peer review at ASIDE Oncology validates the scientific accuracy and relevance of submitted manuscripts, ensuring that published research is trustworthy and significantly advances the field of oncology.

Types of Peer Review

2.1 Double-Blind Peer Review
ASIDE Oncology uses a double-blind peer review process: both reviewers and authors remain anonymous to each other. This minimizes bias and ensures a fair, impartial evaluation based solely on academic and scientific merit.

The Double-Blind Peer Review Process

  • 3.1 Manuscript Submission
    Authors submit manuscripts through the ASIDE Oncology submission system, ensuring no identifying information is present. The editorial team initially assesses suitability based on scope and guidelines.

  • 3.2 Reviewer Selection
    Reviewers are selected based on expertise, prior review history, and impartiality, ensuring appropriate evaluation.

  • 3.3 Conducting the Review
    Reviewers assess significance, originality, methodology, data analysis, and presentation, maintaining confidentiality and declaring any conflicts of interest.

  • 3.4 Reviewer Recommendations
    Reviewers provide recommendations (accept, minor revision, major revision, or reject) and constructive feedback to enhance clarity and robustness.

  • 3.5 Decision Making
    The editorial team considers all feedback, and may consult additional reviewers in cases of conflicting opinions.

  • 3.6 Revision and Re-review
    Authors address reviewer comments and may undergo further review rounds as needed.

  • 3.7 Acceptance and Publication
    Manuscripts meeting standards proceed to copyediting, layout, proofing, and publication.

Why Double-Blind Peer Review?
Double-blind review enhances impartiality and credibility, focusing solely on scientific merit.

Ensuring Integrity and Fairness
ASIDE Oncology is committed to the integrity of peer review. Any attempts to circumvent the double-blind process will be addressed seriously.

Conclusion
Our process upholds the highest standards of integrity and publication quality, contributing valuable knowledge to oncology.

Policies on Editorial Involvement and Endogeny for ASIDE Oncology

Policy on Editorial Involvement in Manuscripts

If the Editor-in-Chief, an Associate Editor, or any editorial board member is a co-author on a submission, they must recuse themselves from the review process. A qualified editor without a conflict will manage the review to ensure impartiality.

Editorial members who are co-authors have no access to the review process or influence over decisions regarding their manuscript, ensuring integrity and fairness.

 

Ethical Standards for ASIDE Oncology

Introduction

ASIDE Oncology adheres to the code of ethics outlined by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), the Open Access Scholarly Publishers Association (OASPA), and the Think. Check. Submit. initiative. These guidelines uphold the highest standards of integrity, transparency, and fairness in all publishing practices.

1. Editorial Standards

  • Integrity: Committed to ethical guidelines by COPE and ICMJE.

  • Fair Play: Manuscripts are evaluated solely on content, regardless of race, gender, sexual orientation, religion, ethnicity, citizenship, or political views.

  • Confidentiality: Editorial staff maintain strict confidentiality throughout the review process.

2. Duties of Reviewers

  • Contribution to Decisions: Peer review supports editorial decisions and helps authors improve their work.

  • Promptness: Reviewers should promptly accept or decline invitations, and excuse themselves if unqualified or unavailable.

  • Confidentiality: All submissions are confidential.

  • Objectivity: Reviews are conducted objectively, avoiding personal criticism and providing clear, supported arguments.

  • Conflict of Interest: Reviewers should decline reviews where a conflict exists.

3. Duties of Authors

  • Reporting Standards: Original research must be reported accurately and objectively.

  • Data Access: Authors may be required to provide underlying data.

  • Originality and Attribution: All sources must be appropriately cited.

  • Redundant Publication: Manuscripts should not duplicate previously published work.

  • Authorship: Authorship is limited to those who made significant contributions.

  • Disclosure: All conflicts of interest must be disclosed.

4. Publishing Ethics Issues

  • Monitoring Ethics: The editorial board monitors compliance with COPE guidelines and addresses misconduct.

  • Retraction Policy: In cases of confirmed misconduct, ASIDE Oncology will retract affected publications to protect the scientific record.

Our commitment to ethical practices ensures every article meets the highest standards in biomedical publishing. For questions, contact the editorial office at [email protected].